From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Top Story

Lifetime Risk for Stroke

It’s at least as high as the lifetime risk for Alzheimer disease, according to Framingham Heart Study data.

These researchers estimated the lifetime risk for stroke among 4897 Framingham Heart Study participants who were stroke- and dementia-free at age 55. Maximum follow-up was 51 years for stroke and 29 years for dementia.

During follow-up, 875 participants (18%) had a first stroke (86% ischemic). The lifetime risk for stroke remained constant from age 55 to 75: about 1 in 5 for women and 1 in 6 for men. At age 85, the lifetime risk for stroke dropped to about 1 in 6 for women and 1 in 10 for men. Regardless of age, hypertensive participants had a consistently greater risk for stroke than did normotensive participants, even when users of antihypertensive drugs were excluded.

Four hundred participants (14%) developed dementia (73% with Alzheimer disease) during follow-up. Among people who reached age 65, the lifetime risk for AD was roughly 1 in 5 for women and 1 in 10 for men. These risks did not vary according to BP level.

Comment: These data document a lifetime risk for stroke in middle-aged adults at about 1 in 6, at least as high as the risk for developing Alzheimer disease. Given that hypertension was shown (once again) to be an important determinant of stroke risk, one would expect achieving normal BP to reduce the risk significantly, although this observational study did not address the effect of interventions.

— Joel M. Gore, MD

Published in Journal Watch Cardiology December 27, 2006

Citation(s):

Seshadri S et al. The lifetime risk of stroke: Estimates from the Framingham Study. Stroke 2006 Feb; 37:345-50.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.